Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
2015 · New England Journal of Medicine · 5,799 citations
https://doi.org/10.1056/nejmoa1510665
F
Frede Donskov
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
369
Papers
29.1K
Citations
62
h-index
171
i10-index
Frede Donskov is an academic researcher from Aarhus University Hospital. The author has contributed to research in topics: Renal cell carcinoma treatment & Cancer Genomics and Diagnostics & Renal and related cancers. The author has an h-index of 62, co-authored 314 publications.
ORCID: 0000-0002-8449-863XPapers by this author
worksAtezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial
2019 · The Lancet · 988 citations
https://doi.org/10.1016/s0140-6736(19)30723-8
Presence of Intratumoral Neutrophils Is an Independent Prognostic Factor in Localized Renal Cell Carcinoma
2009 · Journal of Clinical Oncology · 468 citations
https://doi.org/10.1200/jco.2008.18.9498
Nivolumab versus everolimus in patients with advanced renal cell carcinoma: Updated results with long‐term follow‐up of the randomized, open‐label, phase 3 CheckMate 025 trial
2020 · Cancer · 331 citations
https://doi.org/10.1002/cncr.33033
Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended 8-year follow-up results of efficacy and safety from the phase III CheckMate 214 trial
2024 · Annals of Oncology · 157 citations
https://doi.org/10.1016/j.annonc.2024.07.727
Change in Neutrophil-to-lymphocyte Ratio in Response to Targeted Therapy for Metastatic Renal Cell Carcinoma as a Prognosticator and Biomarker of Efficacy
2016 · European Urology · 147 citations
https://doi.org/10.1016/j.eururo.2016.02.033
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat